Clinical trial
Dexamethasone as an Adjuvant to Ropivacaine for the Interscalene Brachial Plexus Block: a Dose-finding Study
NCT02818491 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire Vaudois as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dexamethasone as an Adjuvant to Ropivacaine for the Interscalene Brachial Plexus Block: a Dose-finding Study
- Lead sponsor
- Centre Hospitalier Universitaire Vaudois
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 1, 2017
- Completion date
- November 1, 2018
- Enrollment
- 75 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.